Mostrar el registro sencillo del ítem
dc.contributor.author | Fernández Landa, Julen | |
dc.contributor.author | Fernández Lázaro, Diego | |
dc.contributor.author | Calleja González, Julio | |
dc.contributor.author | Caballero García, Alberto | |
dc.contributor.author | Córdova Martínez, Alfredo | |
dc.contributor.author | León Guereño, Patxi | |
dc.contributor.author | Mielgo Ayuso, Juan Francisco | |
dc.date.accessioned | 2022-03-24T10:52:59Z | |
dc.date.available | 2022-03-24T10:52:59Z | |
dc.date.issued | 2020 | |
dc.identifier.citation | Biomolecules, 2020, vol. 10, n. 1, 140 | es |
dc.identifier.issn | 2218-273X | es |
dc.identifier.uri | https://uvadoc.uva.es/handle/10324/52632 | |
dc.description | Producción Científica | es |
dc.description.abstract | Creatine monohydrate (CrM) and β-hydroxy β-methylbutyrate (HMB) are widely studied ergogenic aids. However, both supplements are usually studied in an isolated manner. The few studies that have investigated the effect of combining both supplements on exercise-induced muscle damage (EIMD) and hormone status have reported controversial results. Therefore, the main purpose of this study was to determine the effect and degree of potentiation of 10 weeks of CrM plus HMB supplementation on EIMD and anabolic/catabolic hormones. This study was a double-blind, placebo-controlled trial where participants (n = 28) were randomized into four different groups: placebo group (PLG; n = 7), CrM group (CrMG; 0.04 g/kg/day of CrM; n = 7), HMB group (HMBG; 3 g/day of HMB; n = 7), and CrM-HMB group (CrM-HMBG; 0.04 g/kg/day of CrM plus 3 g/day of HMB; n = 7). Before (baseline, T1) and after 10 weeks of supplementation (T2), blood samples were collected from all rowers. There were no significant differences in the EIMD markers (aspartate aminotransferase, lactate dehydrogenase, and creatine kinase) among groups. However, we observed significant differences in CrM-HMBG with respect to PLG, CrMG, and HMBG on testosterone (p = 0.006; η2p = 0.454) and the testosterone/cortisol ratio (T/C; p = 0.032; η2p = 0.349). Moreover, we found a synergistic effect of combined supplementation on testosterone (CrM-HMBG = −63.85% vs. CrMG + HMBG = −37.89%) and T/C (CrM-HMBG = 680% vs. CrMG + HMBG = 57.68%) and an antagonistic effect on cortisol (CrM-HMBG = 131.55% vs. CrMG + HMBG = 389.99%). In summary, the combination of CrM plus HMB showed an increase in testosterone and T/C compared with the other groups after 10 weeks of supplementation. Moreover, this combination presented a synergistic effect on testosterone and T/C and an antagonistic effect on cortisol compared with the sum of individual or isolated supplementation. | es |
dc.format.mimetype | application/pdf | es |
dc.language.iso | eng | es |
dc.publisher | MDPI | es |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | es |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject.classification | Muscle damage | es |
dc.subject.classification | Daño muscular | es |
dc.subject.classification | Lactate dehydrogenase | es |
dc.subject.classification | Lactato deshidrogenasa | es |
dc.subject.classification | Creatine kinase | es |
dc.subject.classification | Creatina quinasa | es |
dc.subject.classification | Testosterone | es |
dc.subject.classification | Testosterona | es |
dc.title | Long-term effect of combination of creatine monohydrate plus β-Hydroxy β-Methylbutyrate (HMB) on exercise-induced muscle damage and anabolic/catabolic hormones in elite male endurance athletes | es |
dc.type | info:eu-repo/semantics/article | es |
dc.rights.holder | © 2020 The Authors | es |
dc.identifier.doi | 10.3390/biom10010140 | es |
dc.relation.publisherversion | https://www.mdpi.com/2218-273X/10/1/140 | es |
dc.peerreviewed | SI | es |
dc.rights | Atribución 4.0 Internacional | * |
dc.type.hasVersion | info:eu-repo/semantics/publishedVersion | es |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
La licencia del ítem se describe como Atribución 4.0 Internacional